Relay Therapeutics Enters Agreement With Genentech To Develop Tumor Treatment

Relay Therapeutics recently announced it has entered a global license and collaboration agreement with Genentech in order to develop a tumor treatment. The two companies aim to broaden small molecule inhibitor treatments through this agreement...